Emerging Infectious Disease ISSN: 1080-6059

Imported Ciprofloxacin-Resistant Neisseria meningitidis

Giuseppe Lapadula

, Franco Viganò, Paolo Fortuna, Alberto Dolara, Simone Bramati, Alessandro Soria, Sergio Foresti, and Andrea Gori

Author affiliations: San Gerardo Hospital, Monza, Italy

Figure

Antimicrobial drug–susceptibility test, showing resistance to levofloxacin (LEV, lower strip), ciprofloxacin (CIP, upper strip), and nalidixic acid (NA, disk) for the strain of Neisseria meningitidis isolated from the patient.

Figure. Antimicrobial drug–susceptibility test, showing resistance to levofloxacin (LEV, lower strip), ciprofloxacin (CIP, upper strip), and nalidixic acid (NA, disk) for the strain of Neisseria meningitidis isolated from the patient.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.